LobbyingAmerican Academy of Family Physicians lobbying by quarter
American Academy of Family Physicians's latest lobbying report covers Q2 2026, at $1.1M. The four quarters Q4 2025–Q3 2026 total $2.7M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
American Academy of Family Physicians
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2.7M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $848K | 2 |
| Q1 2023 | $804.9K | 2 |
| Q2 2023 | $864.9K | 2 |
| Q3 2023 | $846.3K | 2 |
| Q4 2023 | $876.8K | 2 |
| Q1 2024 | $885K | 2 |
| Q2 2024 | $1.1M | 2 |
| Q3 2024 | $988.7K | 2 |
| Q4 2024 | $1.1M | 2 |
| Q1 2025 | $1.2M | 3 |
| Q2 2025 | $1.3M | 3 |
| Q3 2025 | $880.5K | 3 |
| Q4 2025 | $787.9K | 3 |
| Q1 2026 | $804K | 3 |
| Q2 2026 | $1.1M | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$3M · 32 reports
- Medicare and Medicaid$2.9M · 30 reports
- Budget and appropriations$2.3M · 15 reports
- Education$2.3M · 15 reports
- Immigration$2.3M · 15 reports
- Taxation$1.5M · 10 reports
- Insurance$112.6K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
- Health & Human Services, Dept of (HHS)22 reports
- Centers For Medicare and Medicaid Services (CMS)19 reports
- Executive Office of the President (EOP)4 reports
- Health Resources & Services Administration (HRSA)4 reports
- Drug Enforcement Administration (DEA)2 reports
- Office of Management & Budget (OMB)2 reports
- Substance Abuse & Mental Health Services Administration (SAMHSA)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Academy of Family Physicians | $13.3M | 15 quarters |
| Splitoak Strategies | $900K | 15 quarters |
| Cozen O'Connor Public Strategies | $280K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| AMY JENSEN | 1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Special Affairs | Q2 2026 |
| ARIELLE WORONOFF | Counsel, Rep. Sandy Levin (10/2012-3/2014); Leg. Asst, Sen. Booker, (3/2014-1/2015); Health Counsel, House E&C Committee, Pallone (1/2015-3/2017), Sr. Health Counsel, Sen. Finance Cmte, Wyden (3/2017-2/2021);Dir. OL, Dep. Chief of Staff, CMS, 2021-24 | Q2 2026 |
| DAVID TULLY | Senior Legislative Assistant - Rep. Kay Granger (R-Tx) | Q2 2026 |
| SARAH KUEHL EGGE | 1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Senator Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction | Q2 2026 |
| ALEXANDRA CAMPAU | Health Policy Advisor and Counsel, House Budget Committee; Health Policy Counsel, Senate Republican Policy Committee; Special Assistant to the President for Health Policy, The White House/Executive Office of the President; Beachhead team member - HHS | Q1 2026 |
| ANNA SCHAUT WALDMAN | Intern - Sen. Kirsten Gillibrand (D-NY) | Q1 2026 |
| KRISTEN ELIZABETH SHATYNSKI | Professional Staff, House E&C Committee to Cathy McMorris Rodgers (2021-22) & Greg Walden (2017-21); Leg. Asst., Rep. Greg Walden, 4/2015-1/2017; Leg. Asst., Rep. Jackie Walorski, 10/2013-4/2015; Leg. Asst., Rep. Devin Nunes, 10/2012-10/2013 | Q2 2024 |
| LYNDON KYLE GERRON | Rep. Joe Barton (R-TX) | Q1 2024 |
| ERICA CISCHKE | Health Insurance Specialist: CMS; Health Policy Advisor: U.S. Senator Al Franken; Health Insurance Specialist: CMS; Program Analyst: HHS | Q1 2023 |
| JOHN AGUILAR | Senior Legislative Assistant: Dec. 2011 - Dec. 2012; Legislative Assistant: Nov. 2010 - Nov. 2011; Staff Assistant: May 2010 - Oct. 2010; - U.S. House of Representatives for Rep. Silvestre Reyes (TX-16). | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Splitoak Strategies | $60K |
| 07/18for Q1 | Cozen O'Connor Public Strategies | $60K |
| 07/15for Q2 | In-house | $1M |
| 04/20for Q1 | Splitoak Strategies | $60K |
| 04/20for Q1 | Cozen O'Connor Public Strategies | $60K |
| 04/14for Q1 | In-house | $684K |
| 01/20for Q4 2025 | Splitoak Strategies | $60K |
| 01/19for Q4 2025 | Cozen O'Connor Public Strategies | $60K |
| 01/15for Q4 2025 | In-house | $667.9K |
| 25/10/20for Q3 2025 | Splitoak Strategies | $60K |
| 25/10/15for Q3 2025 | In-house | $760.5K |
| 25/10/14for Q3 2025 | Cozen O'Connor Public Strategies | $60K |
| 25/10/11for Q3 2024 | Splitoak Strategies | $60K |
| 25/07/21for Q2 2025 | Splitoak Strategies | $60K |
| 25/07/16for Q2 2025 | In-house | $1.2M |
| 25/07/16for Q2 2025 | Cozen O'Connor Public Strategies | $60K |
| 25/04/21for Q1 2025 | Splitoak Strategies | $60K |
| 25/04/18for Q1 2025 | Cozen O'Connor Public Strategies | $40K |
| 25/04/15for Q1 2025 | In-house | $1.1M |
| 25/03/06for Q1 2025 | Cozen O'Connor Public Strategies | Under $5,000 |